| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |